We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Majority of IV Infusion Errors Linked to Clinical Practice

By HospiMedica International staff writers
Posted on 20 Mar 2016
More than half of intravenous (IV) infusion medications contained errors, with majority linked to deviations in hospital policy, according to a new study.

Researchers at Brigham and Women's Hospital (Boston, MA, USA), Concord Hospital (NH, USA), and other institutions conducted a study in ten hospitals in the United States to investigate the types and frequency of IV medication errors associated with smart pumps. More...
Data were collected using a prospective point prevalence approach to capture errors associated with 1,164 smart pump IV administrations to 478 patients, with concurrent evaluation of their potential for harm.

The results showed that of the observed infusions, 699 (60%) had one or more errors associated with their administration, but relatively few of these errors were potentially harmful. The most predominant errors were associated with violations of hospital infusion policy, and included the administration of unauthorized medications, bypassing the smart pump, wrong rate of infusion, labelling errors, and bypassing the integrated drug library.

The researchers suggested that most of these mistakes could be prevented if closed-loop systems, in which the smart pumps are automatically programed with a medication order using the patient’s electronic health record (EHR), were implemented as policy. This would necessitate that a nurse verify the information on the smart pump and accept the data, including drug name, infusion rate, volume, and concentration, before the infusion could begin. The study was published on February 23, 2016, in BMJ Quality & Safety.

“Since these errors are not directly related to the use of smart pumps, these finding suggest that smart pump technology alone cannot fully prevent errors associated with intravenous infusions,” concluded lead author Kumiko Schnock, MD, of Brigham and Women's Hospital, and colleagues. “The results of this study will be useful in developing interventions to eliminate errors in the intravenous medication administration process.”

Smart infusion pumps were developed to reduce adverse drug events and medication administration errors through built-in safety features, such as built-in drug libraries and dose error reduction systems. According to a national survey conducted by the American Society of Health-System Pharmacists (Bethesda, MD, USA), in 2012 77% of hospitals in the United States use smart pump technology.

Related Links:

Brigham and Women's Hospital
Concord Hospital
American Society of Health-System Pharmacists



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Annotation platform for pixel-level labeling of free-text findings in 3D chest CT. (Baharoon M, Luo L, Moritz M, et al. ReXGroundingCT: A 3D chest CT dataset for segmentation of findings from free-text reports. NEJM AI. 2026;3(7). doi:10.1056/AIdbp2501220.)

Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology

Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.